Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Generalized Anxiety Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

876

Participants

Timeline

Start Date

April 30, 2006

Study Completion Date

August 31, 2007

Conditions
Generalized Anxiety Disorder
Interventions
DRUG

Quetiapine fumarate

Trial Locations (58)

Unknown

Research Site, Springdale

Research Site, Little Rock

Research Site, Encino

Research Site, Newport Beach

Research Site, Oceanside

Research Site, Redlands

Research Site, Santa Ana

Research Site, Denver

Research Site, Norwich

Research Site, Washington D.C.

Research Site, Fort Walton Beach

Research Site, Gainsville

Research Site, Hialeah

Research Site, Jacksonville

Research Site, Miami

Research Site, Orlando

Research Site, Tampa

Research Site, Winter Park

Research Site, Atlanta

Research Site, Smyrna

Research Site, Eagle

Research Site, Chicago

Research Site, Oak Brook

Research Site, Indianapolis

Research Site, Topeka

Research Site, New Orleans

Research SIte, Fall River

Research Site, Farmington Hills

Research Site, Ridgeland

Research Site, St Louis

Research Site, Las Vegas

Research Site, Cherry Hill

Research Site, Clementon

Research Site, Brooklyn

Research Site, New York

Research Site, Rochester

Research Site, Staten Island

Research Site, Charlotte

Research Site, Durham

Research Site, Cincinnati

Research Site, Toledo

Research Site, Oklahoma City

Research Site, Tulsa

Research Site, Portland

Research Site, Allentown

Research Site, Norristown

Research Site, Lincoln

Research Site, Memphis

Research Site, Austin

Research Site, Dallas

Research Site, Friendswood

Research Site, San Antonio

Research Site, Woodstock

Research Site, Herndon

Research Site, Midlothian

Research Site, Bellevue

Research Site, Seattle

Research Site, Charleston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY